These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 27520753)
1. The Role of Metabolites of Antidepressants in the Treatment of Depression. Rudorfer MV; Potter WZ CNS Drugs; 1997 Apr; 7(4):273-312. PubMed ID: 27520753 [TBL] [Abstract][Full Text] [Related]
2. Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications. Caccia S Clin Pharmacokinet; 1998 Apr; 34(4):281-302. PubMed ID: 9571301 [TBL] [Abstract][Full Text] [Related]
3. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder. Foster RH; Goa KL CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Sánchez C; Hyttel J Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421 [TBL] [Abstract][Full Text] [Related]
6. Recent pharmacologic advances in antidepressant therapy for the elderly. Preskorn SH Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477 [TBL] [Abstract][Full Text] [Related]
8. [Fluoxetine: an update of its use in major depressive disorder in adults]. Gourion D; Perrin E; Quintin P Encephale; 2004; 30(4):392-9. PubMed ID: 15597466 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the newer antidepressants: clinical relevance. DeVane CL Am J Med; 1994 Dec; 97(6A):13S-23S. PubMed ID: 7992822 [TBL] [Abstract][Full Text] [Related]
11. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression. Davis R; Wilde MI CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050 [TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence. Sproule BA; Naranjo CA; Brenmer KE; Hassan PC Clin Pharmacokinet; 1997 Dec; 33(6):454-71. PubMed ID: 9435993 [TBL] [Abstract][Full Text] [Related]
13. Clinically significant drug interactions with antidepressants in the elderly. Spina E; Scordo MG Drugs Aging; 2002; 19(4):299-320. PubMed ID: 12038880 [TBL] [Abstract][Full Text] [Related]
15. Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development. Montgomery S Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():5-11. PubMed ID: 24921676 [TBL] [Abstract][Full Text] [Related]
16. [Clinically relevant drug interactions with new generation antidepressants and antipsychotics]. Eckert A Ther Umsch; 2009 Jun; 66(6):485-92. PubMed ID: 19496045 [TBL] [Abstract][Full Text] [Related]
17. Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents. Flint AJ Drugs Aging; 1998 Oct; 13(4):269-80. PubMed ID: 9805208 [TBL] [Abstract][Full Text] [Related]
18. Severe depression: is there a best approach? Sonawalla SB; Fava M CNS Drugs; 2001; 15(10):765-76. PubMed ID: 11602003 [TBL] [Abstract][Full Text] [Related]
19. Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment. Daniel WA; Haduch A; Syrek M; Boksa J Eur Neuropsychopharmacol; 2006 Dec; 16(8):580-7. PubMed ID: 16503401 [TBL] [Abstract][Full Text] [Related]